Dedicated to design & manufacturing for medical device
25-27 September 2019 | Shanghai,China
2019.08.14 Roche Expands Global Access to Viral Assays to Aid Eradication Efforts
Access to diagnostic assays is key to achievement of the World Health Organization’s infectious disease elimination goals.
2019.07.18 Intuitive Is the Latest Surgical Robotics Company to Level Up
The Sunnyvale, CA-based company’s acquisition of the robotic endoscope portion of Schölly Fiberoptic’s business follows strategic moves by Medtronic and Verb Surgical to strengthen their respective robotics platforms.
2019.04.30 No More Patent Drama Between Neovasc and Edwards?
Neovasc said it had resolved the three claims of correction of patent inventorship made by Irvine, CA-based Edwards Lifesciences.
2019.03.21 Apple’s Watch Shows It Has ‘Heart’ in New Study
The Cupertino, CA-based company released preliminary data from the Apple Heart Study, which demonstrates the effectiveness of wearables to detect atrial fibrillation.
2019.03.11 Carestream Sheds Health IT Business
The company said it will sell its health information systems business unit to Philips. The deal is expected to close later this year.
2019.01.02 Latest Boston Sci Deal Shakes up Mitral Repair Market
The Marlborough, MA-based company strengthens its structural heart portfolio and gains a deeper foothold in a market where Medtronic, Abbott Laboratories, and Edwards Lifesciences have already made significant acquisitions.
2018.12.28 How Boston Scientific Reinvented Itself in 2018
Boston Scientific is Editor’s Choice for 2018 Company of the Year because of its numerous acquisitions, meticulous planning, and its unwillingness to stay silent when tackling controversy. The Marlborough, MA-based company is on the cusp of change.
2018.12.03 J&J Subsidiary Launches IDE Study for AF
The study will evaluate Biosense Webster's Heliostar radiofrequency balloon ablation catheter for the treatment of symptomatic drug refractory recurrent paroxysmal (intermittent) atrial fibrillation.
2018.11.13 Another Chance for Medtronic’s Renal Denervation Therapy
The Dublin-based company has received FDA approval to begin a clinical trial to evaluate the Symplicity Spyral renal denervation system with patients on medication for high blood pressure.
2018.09.12 Medtronic Is an Example of Why Diversity Matters
Medtronic has been ranked third on the 2018 Thomson Reuters Diversity and Inclusion Index, jumping ten spots from number 13, which it held in 2016 and 2017.